Teriparatide (original) (raw)

• Fresh from the Pipeline
• Published: 01 April 2003

Nature Reviews Drug Discovery volume 2, pages 257–258 (2003)Cite this article

• 1613 Accesses
• 64 Citations
• 6 Altmetric
• Metrics details

Abstract

Teriparatide (Forteo; Eli Lilly), a recombinant form of the 34 amino-terminal amino acids of human parathyroid hormone, was approved by the US FDA in November 2002 for the treatment of osteoporosis. As the first agent to stimulate bone formation, rather than just reduce bone loss, what impact is it likely to have on the osteoporosis drug market?

References

1. Goltzman, D. Discoveries, drugs and skeletal disorders. Nature Rev. Drug Discov. 1, 784–796 (2002).
   Article CAS Google Scholar
2. Cummings, S. R. & Melton, L. J. Epidemiology and outcomes of osteoporotic fractures. Lancet 359, 1761–1767 (2002).
   Article Google Scholar
3. Rubin, M. R. & Bilezikian, J. P. New anabolic therapies in osteoporosis. Curr. Opin. Rheumatol. 14, 433–440 (2002).
   Article CAS Google Scholar
4. FDA Drug Approvals List [online] (cited 28 February 2003) < http:2002/21318_forteo_lbl.pdf > (2002).
5. Neer, R. et al. Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N. Engl. J. Med. 344, 1434–1441 (2001).
   Article CAS Google Scholar
6. Orwoll, E. S. et al. The effect of teriparatide [human parathyroid hormone (1–34)] therapy on bone density in men with osteoporosis. J. Bone Miner. Res. 18, 9–17 (2003).
   Article CAS Google Scholar
7. Lilly Forteo risk management program limits launch to 8,000 doctors. The Pink Sheet 64, 7–8 (2002).

Download references

Author information

Authors and Affiliations

1. Decision Resources Inc., 260 Charles Street, Waltham, 020453, Massachusetts, USA
   Carilee Berg & Kat Neumeyer
2. Nature Reviews Drug Discovery,
   Peter Kirkpatrick

Authors

1. Carilee Berg
2. Kat Neumeyer
3. Peter Kirkpatrick

Corresponding author

Correspondence toCarilee Berg.

Rights and permissions

About this article

Cite this article

Berg, C., Neumeyer, K. & Kirkpatrick, P. Teriparatide.Nat Rev Drug Discov 2, 257–258 (2003). https://doi.org/10.1038/nrd1068

Download citation

• Issue date: 01 April 2003
• DOI: https://doi.org/10.1038/nrd1068

This article is cited by